SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 278 filers reported holding SAGE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $278,000 | -46.7% | 3,854 | +3.5% | 0.01% | -50.0% |
Q3 2019 | $522,000 | -23.6% | 3,723 | -0.3% | 0.02% | -25.9% |
Q2 2019 | $683,000 | +22.6% | 3,733 | +6.5% | 0.03% | +17.4% |
Q1 2019 | $557,000 | +76.3% | 3,505 | +6.2% | 0.02% | +53.3% |
Q4 2018 | $316,000 | -31.9% | 3,300 | +0.4% | 0.02% | -21.1% |
Q3 2018 | $464,000 | – | 3,288 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 312,000 | $29,886,000 | 5.11% |
DAFNA Capital Management LLC | 104,306 | $9,991,000 | 4.97% |
Palo Alto Investors LP | 850,977 | $81,515,000 | 4.34% |
BB BIOTECH AG | 1,375,229 | $131,733,000 | 4.22% |
Eventide Asset Management | 936,000 | $89,659,000 | 3.97% |
TRV GP II, LLC | 37,362 | $3,579,000 | 3.56% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 146,179 | $14,002,000 | 2.11% |
SUFFOLK CAPITAL MANAGEMENT LLC | 111,908 | $10,720,000 | 2.06% |
OAK RIDGE INVESTMENTS LLC | 231,483 | $22,174,000 | 1.60% |
Rhenman & Partners Asset Management AB | 137,339 | $13,156,000 | 1.50% |